Cost of Patients With Hemophilia A and High-Titer Inhibitors in Colombia.
Sign Up to like & getrecommendations! Published in 2019 at "Value in health regional issues"
DOI: 10.1016/j.vhri.2019.08.473
Abstract: BACKGROUND In Colombia, hemophilia is considered a high-cost disease, and hemophilia A with high-titer inhibitors may be responsible for a significant economic pressure on the Colombian health system. OBJECTIVES To estimate the direct cost of… read more here.
Keywords: patients hemophilia; titer inhibitors; hemophilia high; high titer ... See more keywords